UBS Group Lowers Amrize (NYSE:AMRZ) Price Target to $42.00

Key Points

• UBS cut Amrize’s price target to $42 from $57 while maintaining a “neutral” rating, implying roughly 7.6% upside from the stock’s $39.04 price. The analyst consensus remains “Hold,” with a $53.31 target.
• Amrize shares have declined from recent levels, trading near their 52-week low of $37.38; the company also missed quarterly earnings expectations, reporting $0.88 per share versus the $0.92 consensus.
• Company insiders have been buying shares: executives acquired nearly 49,000 shares worth approximately $2.16 million over the past 90 days, including CEO Jan Jenisch’s purchase of 26,000 shares.

Amrize (NYSE:AMRZ - Get Free Report) had its price objective dropped by equities research analysts at UBS Group from $57.00 to $42.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a "neutral" rating on the stock. UBS Group's price target points to a potential upside of 7.59% from the company's current price.

Other equities analysts also recently issued research reports about the stock. William Blair set a $40.00 price target on shares of Amrize in a research note on Wednesday, September 2nd. Citigroup downgraded Amrize from a "buy" rating to a "cautious" rating in a report on Wednesday, September 9th. Weiss Ratings downgraded shares of Amrize from a "hold (c)" rating to a "hold (c-)" rating in a research note on Monday, August 31st. Sanford C. Bernstein restated an "outperform" rating and issued a $60.00 price objective on shares of Amrize in a report on Monday. Finally, Wells Fargo & Company reissued an "equal weight" rating and issued a $44.00 target price (down from $55.00) on shares of Amrize in a report on Wednesday, September 9th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have given a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $53.31.

Amrize Price Performance

Shares of Amrize stock traded up $0.45 on Tuesday, hitting $39.04. 1,081,105 shares of the company were exchanged, compared to its average volume of 3,344,158. The company has a 50-day moving average price of $45.77 and a 200 day moving average price of $51.38. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $21.59 billion, a price-to-earnings ratio of 18.02, a price-to-earnings-growth ratio of 1.16 and a beta of 0.04. Amrize has a 1-year low of $37.38 and a 1-year high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The company had revenue of $3.49 billion for the quarter. As a group, sell-side analysts predict that Amrize will post 2.57 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Jan Jenisch purchased 26,000 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The stock was purchased at an average cost of $42.47 per share, for a total transaction of $1,104,220.00. Following the acquisition, the chief executive officer owned 1,767,000 shares in the company, valued at approximately $75,044,490. This trade represents a 1.49% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Baris Oran acquired 3,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was purchased at an average cost of $47.38 per share, with a total value of $142,140.00. Following the transaction, the chief financial officer directly owned 3,000 shares of the company's stock, valued at $142,140. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders acquired 48,983 shares of company stock worth $2,158,755. 0.54% of the stock is owned by insiders.

Institutional Trading of Amrize

Hedge funds have recently made changes to their positions in the stock. Norges Bank acquired a new stake in Amrize during the fourth quarter worth about $929,333,000. Barclays PLC lifted its stake in shares of Amrize by 95.4% in the 4th quarter. Barclays PLC now owns 4,614,593 shares of the company's stock worth $249,557,000 after acquiring an additional 2,253,431 shares during the period. National Pension Service acquired a new stake in shares of Amrize in the 4th quarter worth approximately $87,784,000. DJE Kapital AG boosted its holdings in shares of Amrize by 2,005.4% in the fourth quarter. DJE Kapital AG now owns 762,887 shares of the company's stock valued at $41,986,000 after acquiring an additional 726,652 shares in the last quarter. Finally, First Manhattan CO. LLC. increased its stake in shares of Amrize by 20.0% during the fourth quarter. First Manhattan CO. LLC. now owns 4,036,704 shares of the company's stock valued at $218,305,000 after acquiring an additional 672,030 shares during the period.

Amrize Company Profile

Amrize is a North American building materials and solutions company formed through the separation of Holcim's North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.